Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

Basit Öğe Kaydı
dc.contributor.authorTural, D.
dc.contributor.authorOlmez, O. F.
dc.contributor.authorSumbul, A. T.
dc.contributor.authorOzhan, N.
dc.contributor.authorAkar, E.
dc.contributor.authorCakar, B.
dc.contributor.authorKostek, O.
dc.date.accessioned2024-02-23T14:02:05Z
dc.date.available2024-02-23T14:02:05Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.descriptionESMO Virtual Congress -- SEP 19-OCT 18, 2020 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.doi10.1016/j.annonc.2020.08.853
dc.identifier.endpageS598en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS598en_US
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2020.08.853
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11577
dc.identifier.volume31en_US
dc.identifier.wosWOS:000573469101069en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titlePrognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumaben_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu